Embryonic Testing, Dignity, and Freedom of Choice: A Report
VerifiedAdded on 2023/01/17
|7
|1498
|82
Report
AI Summary
This report explores the ethical and moral implications of embryonic testing, specifically focusing on preimplantation genetic diagnosis (PGD) and its relationship to dignity and freedom of choice. The report provides background on the advancements in scientific technologies, particularly in relation to the human genome and genetic disorders, and the ability to test for genetic diseases. The report discusses the process of PGD, which allows for the selection of embryos based on their genetic suitability, and the advantages of this process, such as preventing genetic disorders and allowing for gender selection in certain cultural contexts. The report then delves into the concept of human dignity, emphasizing the inherent moral value of each individual and the moral rights that stem from it, including the right to life. The report argues that embryonic testing, while offering freedom of choice to couples, can potentially violate the dignity of the embryo by creating and destroying life, and by denying embryos the opportunity to compete naturally. The conclusion supports embryonic testing for the selection of desirable genetic traits, while acknowledging the ethical complexities and the differing perspectives on when life begins.
1 out of 7